• M.meghana
• K.krishna

retrospective observational study design, to compare and determine better therapeutically active against coronaviruses according to both (1st wave & 2nd wave) protocol drugs. The number of COVID-19 cases in India is increasing day by day. There are no properly licensed drugs for COVID-19 but asymptomatic and supportive therapy is provided by the world health organization (WHO), the international council of medical research (ICMR), food and drug administration (FDA), & the national institute for healthcare and excellence (NICE), National center for disease control (NCDC) this committee monitoring &ensuring proper essential health services to the COVID patients. The aim of this study is to evaluate the drugs used in the first wave with the second wave drugs and compare the most benefit able drug in COVID-19 patients.

retrospective comparative study design, COVID-19, 1st wave drugs protocol & 2nd wave drugs protocol

"Comparision of different types of drugs used in COVID wave-1 & wave-2", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 8, page no.a133-a143, August-2021, Available :http://www.jetir.org/papers/JETIR2108019.pdf

"Comparision of different types of drugs used in COVID wave-1 & wave-2", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 8, page no. ppa133-a143, August-2021, Available at : http://www.jetir.org/papers/JETIR2108019.pdf